• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

5

CATEGORIES

  • 10
  • 7
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

1
5
6
22

PUBLISHED

0
0
2
22

PRODUCT TYPE

22

Search "Elan Corporation, plc - Product Pipeline Review - 2012" returned 22 results.

PRODUCT TITLE
Demyelinating Diseases - Pipeline Review, H2 2012 Demyelinating Diseases - Pipeline Review, H2 2012 - Product Thumbnail Image

Demyelinating Diseases - Pipeline Review, H2 2012

Demyelinating Diseases – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Demyelinating Diseases - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline....

December 2012
FROM
Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H1 2013 Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H1 2013 - Product Thumbnail Image

Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H1 2013

Relapsing Multiple Sclerosis (RMS) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2013', provides an overview of the indication’s...

April 2013
FROM
Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2012 Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2012 - Product Thumbnail Image

Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2012

Bipolar Disorder (Manic Depression) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2012', provides an overview of the Bipolar...

August 2012
FROM
Neurodegenerative Diseases - Pipeline Review, H2 2012 Neurodegenerative Diseases - Pipeline Review, H2 2012 - Product Thumbnail Image

Neurodegenerative Diseases - Pipeline Review, H2 2012

Neurodegenerative Diseases – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Neurodegenerative Diseases - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic...

September 2012
FROM
Primary Systemic Amyloidosis - Pipeline Review, H2 2012 Primary Systemic Amyloidosis - Pipeline Review, H2 2012 - Product Thumbnail Image

Primary Systemic Amyloidosis - Pipeline Review, H2 2012

Primary Systemic Amyloidosis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Primary Systemic Amyloidosis - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic...

October 2012
FROM
Neurology - Pipeline Review, H2 2012 Neurology - Pipeline Review, H2 2012 - Product Thumbnail Image

Neurology - Pipeline Review, H2 2012

Neurology – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Neurology - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information...

December 2012
FROM
Alzheimer's Disease - Pipeline Review, H2 2012 Alzheimer's Disease - Pipeline Review, H2 2012 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Review, H2 2012

Alzheimer's Disease – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Alzheimer's Disease - Pipeline Review, H2 2012', provides an overview of the Alzheimer's Disease therapeutic pipeline....

August 2012
FROM
Multiple Sclerosis - Pipeline Review, H2 2012 Multiple Sclerosis - Pipeline Review, H2 2012 - Product Thumbnail Image

Multiple Sclerosis - Pipeline Review, H2 2012

Multiple Sclerosis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Multiple Sclerosis - Pipeline Review, Global Markets Direct’s, 'Multiple Sclerosis - Pipeline Review, H2 2012', provides...

September 2012
FROM
Depression - Pipeline Review, H2 2012 Depression - Pipeline Review, H2 2012 - Product Thumbnail Image

Depression - Pipeline Review, H2 2012

Depression – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Depression - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides...

October 2012
FROM
Autoimmune Disorders - Pipeline Review, H2 2012 Autoimmune Disorders - Pipeline Review, H2 2012 - Product Thumbnail Image

Autoimmune Disorders - Pipeline Review, H2 2012

Autoimmune Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Autoimmune Disorders - Pipeline Review, H2 2012', provides an overview of the Autoimmune Disorders therapeutic pipeline....

August 2012
FROM
Amyloidosis - Pipeline Review, H2 2012 Amyloidosis - Pipeline Review, H2 2012 - Product Thumbnail Image

Amyloidosis - Pipeline Review, H2 2012

Amyloidosis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Amyloidosis - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides...

September 2012
FROM
Multiple Sclerosis - Pipeline Review, H1 2012 Multiple Sclerosis - Pipeline Review, H1 2012 - Product Thumbnail Image

Multiple Sclerosis - Pipeline Review, H1 2012

Multiple Sclerosis – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Multiple Sclerosis - Pipeline Review, H1 2012', provides an overview of the Multiple Sclerosis therapeutic pipeline....

February 2012
FROM
Parkinson's Disease - Pipeline Review, H1 2012 Parkinson's Disease - Pipeline Review, H1 2012 - Product Thumbnail Image

Parkinson's Disease - Pipeline Review, H1 2012

Parkinson's Disease – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Parkinson's Disease - Pipeline Review, H1 2012', provides an overview of the Parkinson's Disease therapeutic pipeline....

January 2012
FROM
Parkinson's Disease - Pipeline Review, H2 2012 Parkinson's Disease - Pipeline Review, H2 2012 - Product Thumbnail Image

Parkinson's Disease - Pipeline Review, H2 2012

Parkinson's Disease – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Parkinson's Disease - Pipeline Review, H2 2012', provides an overview of the Parkinson's Disease therapeutic pipeline....

July 2012
FROM
Alzheimer's Disease - Pipeline Review, H1 2012 Alzheimer's Disease - Pipeline Review, H1 2012 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Review, H1 2012

Alzheimer's Disease – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Alzheimer's Disease - Pipeline Review, H1 2012', provides an overview of the Alzheimer's Disease therapeutic pipeline....

February 2012
FROM

Nymox Pharmaceutical Corporation (NYMX) - Financial and Strategic SWOT Analysis Review

Nymox Pharmaceutical Corporation (NYMX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been...

May 2014
FROM

Therapeutic Monoclonal Antibodies Markets

Antibodies are proteins in the immune system that help the body defend against foreign invasion, particularly from pathogens and toxins As such, a human-engineered therapeutic monoclonal antibody (mAb)...

June 2009
FROM
Cancer Therapies - Global Strategic Business Report Cancer Therapies - Global Strategic Business Report - Product Thumbnail Image

Cancer Therapies - Global Strategic Business Report

This report analyzes the worldwide markets for Cancer Therapies in US$ Million by the following Product Segments: Immunotherapy, Targeted Therapy, Hormonal Therapy, and Chemotherapy The report provides...

October 2011
FROM

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2013

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2013 Summary Our “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2013”...

April 2013
FROM
Gene Therapy Partnering Terms and Agreements (3rd Edition) Gene Therapy Partnering Terms and Agreements (3rd Edition) - Product Thumbnail Image

Gene Therapy Partnering Terms and Agreements (3rd Edition)

The Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends...

December 2014
FROM
Loading Indicator

Our Clients

Innocent Drinks Ltd. Groupe Danone Cisco Systems, Inc. The World Bank Group Swarovski AG Owens Corning Corporation Swiss Reinsurance Company Ltd.